End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.48 CNY | -0.90% | +0.69% | +2.76% |
05-09 | Hengrui Pharma's Unit Gets Regulatory Nod to Trial HRS-5965 Capsules | MT |
04-26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.76% | 41.3B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+17.06% | 239B | |
+8.07% | 204B | |
-7.73% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 49.24 Yuan From 50.19 Yuan, Keeps at Neutral